ANTITUMOR IMIDAZOTETRAZINES .25. CRYSTAL-STRUCTURE OF 8-CARBAMOYL-3-METHYLIMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE (TEMOZOLOMIDE) AND STRUCTURAL COMPARISONS WITH THE RELATED DRUGS MITOZOLOMIDE AND DTIC

被引:55
|
作者
LOWE, PR [1 ]
SANSOM, CE [1 ]
SCHWALBE, CH [1 ]
STEVENS, MFG [1 ]
CLARK, AS [1 ]
机构
[1] UNIV ASTON, INST PHARMACEUT SCI, BIRMINGHAM B4 7ET, W MIDLANDS, ENGLAND
关键词
D O I
10.1021/jm00096a013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The antitumor imidazotetrazinone, temozolomide (5), C6H6N6O2, forms crystals with unit cell dimensions a = 17.332 (3), b = 7.351 (2), c = 13.247 (1), beta = 109.56 (1)-degrees and space group P2(1)/c. A doubly hydrogen-bonded dimer constitutes the asymmetric unit. One carboxamide group forms an additional intermolecular NH...O hydrogen bond; in both molecules the carboxamide group is coplanar with the heterocycle and its NH2 group interacts with the imidazole nitrogen atom N(7). Molecular orbital calculations show the carbonyl carbon C(4) to be the most electron deficient atom, with relatively weak N(3)-C(4) and C(4)-N(5) bonds confirming that temozolomide should ring-open at this position in solution. The energy barrier to carboxamide group rotation of approximately 20 kJ mol-1 should permit interconversion between rotamers. In temozolomide and the related drug mitozolomide (4), N(7) is more negatively charged than N(1), which favors the formation Of hydrogen bonds to the former atom in spite of their poor geometry. The relevance of these structural features to the action of temozolomide as a major-groove-directed prodrug of the alkylating agent MTIC (3) is discussed.
引用
收藏
页码:3377 / 3382
页数:6
相关论文
共 50 条
  • [21] Pyrido[2′,3′:4,5]pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of temozolomide heteroanalogues
    Diana, Patrizia
    Stagno, Antonina
    Barraja, Paola
    Montalbano, Alessandra
    Martorana, Annamaria
    Carbone, Anna
    Dattolo, Gaetano
    Cirrincione, Girolamo
    ARKIVOC, 2009, : 177 - 186
  • [22] Pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of azolotetrazines with potent antitumor activity
    Diana, P
    Barraja, P
    Lauria, A
    Montalbano, A
    Almerico, AM
    Dattolo, G
    Cirrincione, G
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (11) : 2371 - 2380
  • [23] Synthesis and Antitumor Activity of 3-Methyl-4-oxo-3,4-dihydroimidazo [5,1-d][1,2,3,5]tetrazine-8-carboxylates and -carboxamides
    Liu, Dan
    Yang, Jian-Guo
    Cheng, Jie
    Zhao, Lin-Xiang
    MOLECULES, 2010, 15 (12) : 9427 - 9436
  • [24] Synthesis of trifluoromethyl-promoted functional pyrazolo [1,5-a]pyrimidine and pyrazolo [5,1-d] [1,2,3,5]tetrazine-4(3H)-ones
    Wu, YC
    Chen, YJ
    Li, HJ
    Zou, XM
    Hu, FZ
    Yang, HZ
    JOURNAL OF FLUORINE CHEMISTRY, 2006, 127 (03) : 409 - 416
  • [25] Design and synthesis of novel sulfone-containing pyrazolo[1,5-a]-pyrimidines and pyrazolo[5,1-d][1,2,3,5]tetrazine-4(3H)-ones
    Wu, YC
    Zou, XM
    Hu, FZ
    Yang, HZ
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2005, 42 (04) : 609 - 613
  • [26] Antitumour imidazotetrazines. Synthesis and chemistry of 4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide (nor-temozolomide): an intermediate for the preparation of the antitumour drug temozolomide and analogues, avoiding the use of isocyanates
    Cousin, David
    Stevens, Malcolm F. G.
    Hummersone, Marc G.
    MEDCHEMCOMM, 2012, 3 (11) : 1419 - 1422
  • [27] PYRAZOLE DERIVATIVES .5. SYNTHESIS AND ANTINEOPLASTIC ACTIVITY OF 3-(2-CHLOROETHYL)-3,4-DIHYDRO-4-OXOPYRAZOLO[5,1-D]-1,2,3,5-TETRAZINE-8-CARBOXAMIDE AND RELATED-COMPOUNDS
    CHENG, CC
    ELSLAGER, EF
    WERBEL, LM
    PRIEBE, SR
    LEOPOLD, WR
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (08) : 1544 - 1547
  • [28] Crystal structure of 2-(2-ethoxyphenyl)-7-propyl-5-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one, C17H20N4O2
    wang, Kun-Yan
    Yang, Xiao-Li
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2017, 232 (05): : 703 - 705
  • [29] Synthesis and growth-inhibitory activities of imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamides related to the anti-tumour drug temozolomide, with appended silicon, benzyl and heteromethyl groups at the 3-position
    Cousin, David
    Hummersone, Marc G.
    Bradshaw, Tracey D.
    Zhang, Jihong
    Moody, Christopher J.
    Foreiter, Magdalena B.
    Summers, Helen S.
    Lewis, William
    Wheelhouse, Richard T.
    Stevens, Malcolm F. G.
    MEDCHEMCOMM, 2018, 9 (03) : 545 - 553
  • [30] 3-取代-4-氧-3H-咪唑并[5,1-d][1,2,3,5]四嗪-8-羧酸衍生物抗癌活性的构效关系
    赵蔡斌
    葛红光
    郭小华
    王占领
    孙妩娟
    靳玲侠
    分子科学学报, 2009, 25 (01) : 42 - 45